| Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer. J Palomero, C Panisello, M Lozano-Rabella, R Tirtakasuma, ... Journal for Immunotherapy of Cancer 10 (12), 2022 | 16 | 2022 |
| ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma N Mensali, H Köksal, S Joaquina, P Wernhoff, NP Casey, P Romecin, ... Nature Communications 14 (1), 3375, 2023 | 10 | 2023 |
| An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma C Panisello, R Aschero, H Roca-Ho, A Martínez, CC Ramírez, E de Álava, ... Klinische Pädiatrie 236 (03), 0053, 2024 | | 2024 |
| Blocking TIM3: Galectin-9 pathway enhances in vivo CAR19T cell function A Falgàs, SR Zanetti, A Martínez-Moreno, C Panisello, PA Romecin, ... Klinische Pädiatrie 235 (03), 0014, 2023 | | 2023 |
| An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma C Panisello, C Bueno, C Castilla, R Aschero, AM Carcaboso, E de Álava, ... Klinische Pädiatrie 235 (03), 0038, 2023 | | 2023 |
| An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma C Panisello, C Bueno, AT Amaral, A Carcaboso, EM Álava, P Menendez Klinische Pädiatrie 234 (03), 0023, 2022 | | 2022 |
| Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer C Panisello, R Tirtakasuma, J Díaz-Gómez, D Grases Mendoza, ... BMJ, 2022 | | 2022 |
| 61 Biomarkers of favorable prognosis guides the identification of tumor reactive CD4+ and CD8+ TILs in endometrial cancer J Palomero, C Panisello, A Vidal, J Ponce, A Vivancos, JM Piulats, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| Article published online: 2024-06-05 A Falgàs, SR Zanetti, A Martínez-Moreno, C Panisello, PA Romecin, ... | | |
